Asciminib Roll-over Study
Public ClinicalTrials.gov record NCT04877522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From Continued Treatment
Study identification
- NCT ID
- NCT04877522
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 347 participants
Conditions and interventions
Interventions
- Asciminib single agent Drug
- Asciminib single agent pediatric formulation Drug
- Bosutinib Drug
- Dasatinib Drug
- Imatinib Drug
- Nilotinib Drug
Drug
Eligibility (public fields only)
- Age range
- 7 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2022
- Primary completion
- Aug 28, 2030
- Completion
- Aug 29, 2030
- Last update posted
- Mar 5, 2026
2022 – 2030
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Michigan Med University of Michigan | Ann Arbor | Michigan | 48109 5271 | Recruiting |
| Memorial Sloan Kettering | New York | New York | 10017 | Recruiting |
| Oregon Health Sciences University | Portland | Oregon | 97239 | Active, not recruiting |
| Texas Oncology | Dallas | Texas | 75251 | Recruiting |
| Uni Of TX MD Anderson Cancer Cntr | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04877522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04877522 live on ClinicalTrials.gov.